convEyXO
Pre-clinicalDiscover how ConvEyXO develops innovative RNA-enhanced exosomes to combat degenerative diseases, reduce inflammation, and restore cellular health.
Founded
2018
Focus
Drug Delivery
About
Discover how ConvEyXO develops innovative RNA-enhanced exosomes to combat degenerative diseases, reduce inflammation, and restore cellular health.
Company Info
TypePrivate
Founded2018
LocationLeuven, Belgium
StagePre-clinical
Contact
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile